ABOUT THIS STUDY
- Healthy children previously immunized with 1 or 2 doses of Prevenar.
- Group 1: Male or female subjects between the age of >=140 and <=196 days of age at time of enrollment.
- Group 2: Male or female subjects between the age of >=336 and <=392 days of age at time of enrollment
- Available for entire study period.
- Previous reaction or contra-indication to pneumococcal vaccine or vaccine related
- Previous vaccination with licensed or investigational pneumococcal vaccine other than
TRY A NEW SEARCH
Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Based on your search, you may also be interested in
- Chandler, Arizona
- Pembroke Pines, Florida
- Boise, Idaho
- Raleigh, North Carolina
- Cincinnati, Ohio
- Bristol, Tennessee
- Fajara, The Gambia, West Africa
- Ksmd, The Gambia
- Santiago de Compostela,
- Co Antrim,